domstat.net

Website loading time

during the test: 0.66 s

cable connection (average): 0.76 s

DSL connection (average): 0.86 s

modem (average): 6.19 s

HTTP headers

HTTP/1.1 200 OK

Date: Tue, 18 Oct 2011 03:38:49 GMT

Server: Apache/2.2.3 (CentOS)

X-Powered-By: PHP/5.1.6

Set-Cookie: PHPSESSID=3scuudb0mtvm6o1omc6o9991g5; path=/

Expires: Thu, 19 Nov 1981 08:52:00 GMT

Cache-Control: no-cache,must-revalidate

Pragma: no-cache

Vary: Cookie,Accept-Encoding

Composed-By: SPIP 2.1.10 @ www.spip.net + images(1.0.1), msie_compat(1.0), porte_plume(1.7.8), safehtml(1.3.7), vertebres(1.0), cfg(1.16.0), cextras(1.8.0), mednet(2.0), saisies(1.8.12), notation(0.7.1), spip_bonux(2.2.15), iextras(1.2.2), compresseur(1.0.1)

X-SQL-User: mednet

X-Spip-Cache: 0

Last-Modified: Tue, 18 Oct 2011 03:38:49 GMT

Connection: close

Content-Type: text/html; charset=utf-8

Information about DNS servers

Received from the first DNS server

Request to the server "mednet.ca"
You used the following DNS server:
DNS Name: ns2.meganameservers.com
DNS Server Address: 69.49.97.151#53
DNS server aliases:

HEADER opcode: REQUEST, status: NOERROR, id: 30501
flag: qr aa rd REQUEST: 1, ANSWER: 6, AUTHORITY: 3, ADDITIONAL: 5

REQUEST SECTION:
mednet.ca. IN ANY

ANSWER SECTION:
mednet.ca. 86400 IN A 67.205.89.211
mednet.ca. 86400 IN MX 15 Mail.Global.FrontBridge.com.
mednet.ca. 86400 IN NS ns1.meganameservers.com.
mednet.ca. 86400 IN NS ns2.meganameservers.com.
mednet.ca. 86400 IN NS ns3.meganameservers.com.
mednet.ca. 86400 IN SOA ns1.meganameservers.com. postmaster.meganameservers.com. 2011021716 86400 3600 3600000 86400

AUTHORITY SECTION:
mednet.ca. 86400 IN NS ns1.meganameservers.com.
mednet.ca. 86400 IN NS ns2.meganameservers.com.
mednet.ca. 86400 IN NS ns3.meganameservers.com.

SECTION NOTES:
Mail.Global.FrontBridge.com. 30 IN A 65.55.88.22
Mail.Global.FrontBridge.com. 30 IN A 216.32.180.22
ns1.meganameservers.com. 86400 IN A 69.49.97.150
ns2.meganameservers.com. 86400 IN A 69.49.97.151
ns3.meganameservers.com. 86400 IN A 64.29.144.65

Received 325 bytes from address 69.49.97.151#53 in 20 ms

Received from the second DNS server

Subdomains (the first 50)

Typos (misspells)

Location

IP: 67.205.89.211

continent: NA, country: Canada (CAN), city: Montreal

Website value

rank in the traffic statistics:

There is not enough data to estimate website value.

Basic information

website build using CSS

code weight: 38.74 KB

text per all code ratio: 44 %

title: MedNet Portal

description:

keywords:

encoding: utf-8

language: en

Website code analysis

one word phrases repeated minimum three times

two word phrases repeated minimum three times

three word phrases repeated minimum three times

B tags

U tags

I tags

images

headers

H1

MedNet Portal

H2

Dual Therapy Recommendations in Hypertension: Progress with a Single-pill Combination

Rethinking Prophylaxis of Post-menopausal Risks

Therapeutic Drug Monitoring Emphasized in the Context of Life-threatening Infections

Treating Complicated MRSA in Hospitalized Patients: Comparing IDSA Guidelines with New Data

New Targets for Glycemic Control in the Treatment of Type 2 Diabetes Mellitus

Emerging Therapies for Advanced Ovarian Cancer

Management of Catheter Occlusion and Home Intravenous Chemotherapy: Increasing Patient Safety and Comfort

Complete Remission as a Therapeutic Goal in Rheumatoid Arthritis: Accelerating Research with Biologics and Through New Inflammatory Pathways

Reviving Interest in Lipid Targets Beyond LDL-C: Promising Expansion of Targetable Factors

Advances in the Treatment of Hemophilia B

VACCINE

Achieving Lipid Goals in Patients at Risk of Cardiovascular Disease: Joint EAS/ESC Guidelines

Emerging Options for the Treatment of Type 2 Diabetes Mellitus

Simplifying Immunosuppression for Liver Transplant Recipients: A Lifelong Commitment to Optimize Patient and Graft Survival

Urological Issues in Aging Patients

Solving Common Feeding Difficulties in Paediatrics: A Practical Approach

Advances in Paediatric Immunization: Targeting the Last Remaining Serogroup Towards Complete Meningococcal Disease Control

Appropriate Antibiotic Use: Lessons Learned for Control of Resistance in Children

Daily Asthma Controller Therapy and a Written Action Plan: Keys to Good Asthma Management

Update on Atopic Dermatitis, Cutaneous Infestations in Paediatrics: Focus on Novel Strategies for Improved Control

H3

Dual Therapy Recommendations in Hypertension: Progress with a Single-pill Combination

Rethinking Prophylaxis of Post-menopausal Risks

Therapeutic Drug Monitoring Emphasized in the Context of Life-threatening Infections

Treating Complicated MRSA in Hospitalized Patients: Comparing IDSA Guidelines with New Data

New Targets for Glycemic Control in the Treatment of Type 2 Diabetes Mellitus

Emerging Therapies for Advanced Ovarian Cancer

Management of Catheter Occlusion and Home Intravenous Chemotherapy: Increasing Patient Safety and Comfort

Complete Remission as a Therapeutic Goal in Rheumatoid Arthritis: Accelerating Research with Biologics and Through New Inflammatory Pathways

Reviving Interest in Lipid Targets Beyond LDL-C: Promising Expansion of Targetable Factors

Advances in the Treatment of Hemophilia B

VACCINE

Achieving Lipid Goals in Patients at Risk of Cardiovascular Disease: Joint EAS/ESC Guidelines

Emerging Options for the Treatment of Type 2 Diabetes Mellitus

Simplifying Immunosuppression for Liver Transplant Recipients: A Lifelong Commitment to Optimize Patient and Graft Survival

Urological Issues in Aging Patients

Solving Common Feeding Difficulties in Paediatrics: A Practical Approach

Advances in Paediatric Immunization: Targeting the Last Remaining Serogroup Towards Complete Meningococcal Disease Control

Appropriate Antibiotic Use: Lessons Learned for Control of Resistance in Children

Daily Asthma Controller Therapy and a Written Action Plan: Keys to Good Asthma Management

Update on Atopic Dermatitis, Cutaneous Infestations in Paediatrics: Focus on Novel Strategies for Improved Control

H4

H5

H6

internal links

external links